AIkido Pharma, Inc.(NASDAQ : AIKI)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Biotechnology
|SNSS||Sunesis Pharmaceuticals, Inc.||2.23%||8.71||0.7%||$608.86m|
|REGN||Regeneron Pharmaceuticals, Inc.||-0.20%||651.88||2.7%||$494.43m|
|GILD||Gilead Sciences, Inc.||0.39%||71.61||1.0%||$434.34m|
|VRTX||Vertex Pharmaceuticals, Inc.||0.64%||188.30||1.9%||$241.59m|
|ISEE||IVERIC bio, Inc.||1.59%||16.62||0.0%||$194.78m|
|LIFE||aTyr Pharma, Inc.||0.49%||10.31||3.2%||$144.19m|
|EXAS||EXACT Sciences Corp.||5.22%||108.15||18.1%||$135.69m|
AIkido Pharma, Inc. is a biotechnology development company, which engages in the provision of diversified portfolio of small-molecule anticancer and antiviral therapeutics in development. Its oncology therapeutics includes treatments for pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia. It also creates broad-spectrum antiviral platform, in which the lead compounds have activity against multiple viruses including Influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2, the cause of COVID-19. The company was founded by Gilbert V. Levin and M. Karen Levin in 1967 and is headquartered in New York, NY.